59 search results for: asthma

ERS 2026
Congress
5
September
2026
Congress
ADVENT at ERS 2026

Join Sanofi and Regeneron for four educational symposia on asthma, COPD, and the unified airway.

How Can FeNO Measurement Improve Severe <b>Asthma</b> Management?
Pulmonology
How Can FeNO Measurement Improve Severe Asthma Management?
expert video

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.

View more
Compounded Burden of Co-existing Type 2 Airway Diseases
Pulmonology
Compounded Burden of Co-existing Type 2 Airway Diseases
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Brian Lipworth discusses that co-existing type 2 inflammatory diseases are common in patients with CRSwNP​ & increasing severity of asthma is associated with higher severity of CRS and prevalence of nasal polyps. Additionally, he explains that patient burden is substantially greater when asthma and CRSwNP are co-existing.

View more
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.

thumbnail
Congress
19
October
2026
Congress
ADVENT at CHEST 2026

At CHEST 2026, the Sanofi & Regeneron ADVENT Booth #833 brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

ERS 2026 | Breaking Silos Between <b>Asthma</b> and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease
Pulmonology
ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease
expert video

Join experts Roland Buhl, Joaquim Mullol, and Giselle Mosnaim as they discuss the role of type 2 inflammation across the unified airway, with a focus on the amplified burden and the difficulty controlling inflammation when asthma and CRSwNP coexist.

View more
World Lung Day 2024
Awareness Day
25
September
2024
Awareness Day
World Lung Day 2024

September 25th marks this year’s observance and celebration of World Lung Day!

Mechanisms of Production and Clinical Impact of IgE
Pulmonology
Mechanisms of Production and Clinical Impact of IgE
videoanimation

Explore how type 2 inflammation drives the production of IgE in severe asthma

View more
Exploring the Mechanisms of FeNO Production in the Lungs
Pulmonology
Exploring the Mechanisms of FeNO Production in the Lungs
videoanimation

Explore how type 2 inflammation drives the production of FeNO in severe asthma

View more
Type 2 <b>Asthma</b> Learning Hub
Learning Hub
Type 2 Asthma Learning Hub

Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.

Clinical Manifestations Associated With Airway Remodeling in <b>Asthma</b>
Type 2 Inflammation
Clinical Manifestations Associated With Airway Remodeling in Asthma
expert video

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

View more
ADVENT on Air: OCS in CRSwNP Podcast
Rhinology
ADVENT on Air: OCS in CRSwNP Podcast
Podcast

Listen to experts, Dr. Amber Luong and Dr. Marjolein Cornet, discuss the significant burden of oral corticosteroid (OCS) use in chronic rhinosinusitis with nasal polyps (CRSwNP) and its short-term, long-term, and cumulative risks, particularly for patients with coexisting conditions like asthma. Experts highlight the need for improved multidisciplinary approaches and OCS-sparing strategies to optimize patient care.

View more